Cloning of cDNA Encoding Putative Cellular Receptor Interacting with E2 protein of Hepatitis C Virus |
이성락
(인제대학교 의과대학 미생물학교실)
백재은 (인제대학교 의과대학 미생물학교실) 석대현 (인제대학교 의과대학 미생물학교실) 박세광 (인제대학교 의과대학 미생물학교실) 최인학 (인제대학교 의과대학 미생물학교실) |
1 | Tarasova, N., W. G. Rice and C. J. Michejda. 1999. Inhibition of G-protein coupled receptor function by disruption of transmembrane domain interactions. J. Biol. Chem. 274, 34911-34915. DOI ScienceOn |
2 | Kook, S., D. H. Kim, S. R. Shim, W. Kim, J. S. Chun and W. K. Song. 2003. Caspase-dependent cleavage of tensin induces disruption of actin cytoskeleton during apoptosis. Biochem. Biophys. Res. Commun. 303, 37-45. DOI ScienceOn |
3 | Pulli, T., E. Koivunen and T. Hyypia. 1997. Cellsurface interactions of echovirus 22. J. Biol. Chem. 22, 21176-21180. |
4 | Scarselli, E., H. Ansuini, R. Cerino, R. M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese and A. Vitelli. 2002. The human scavenger receptor class type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017-5025. DOI ScienceOn |
5 | Farci, P., A. Shimoda, D. Wong. T. Carbezon, D. De Gioannis, A. Strazzera, Y. Shimizu, M. Shapiro, H. J. Alter and R. H. Purcell. 1996. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 93, 15394-15399. DOI ScienceOn |
6 | Bertolini, L., S. Lacovacci, A. Ponzetto, G. Gorini, M. Battaglia and G. Carioni. 1993. The human bonemarrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Research in Virol. 144, 281-285. DOI ScienceOn |
7 | Cicchini, C., H. Ansuini, L. Amicone, T. Alonzi, A. Nicosia, R. Cortese, M. Tripodi and A. Luzzago. 2002. Searching for DNA-protein interactions by lambda phage display. J. Mol. Biol. 322, 697-706. DOI ScienceOn |
8 | Pavio, N., D. R. Taylor and M. C. Lai. 2003. Detection of a novel unglycosylated form of hepatitis C virus E2 envelop protein that is located in the cytosol and interacts with PKR. J. Virol. 76, 1265-1272. DOI |
9 | Tayapiwatana, C and W. Kasinrek. 2002. Construction and characterization of phage-displayed leukocyte surface molecule CD99. Appl. Microbiol. Biotechnol. 60, 336-341. DOI |
10 | Mirzabekov, T., N. Bannert, M. Farzan. W. Hofmann, P. Kolchinsky, L. Wu, R. Wyatt and J. Sodroski. 1999. Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor. J. Biol. Chem. 274, 28745-28750. DOI |
11 | Pileri. P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi and S. Abrignani. 1998. Binding of Hepatitis C Virus to CD81. Science 282, 938-941. DOI ScienceOn |
12 | Shimizu, Y. K and H. Yoshikura. 1995. In-vitro systems for the detection of hepatits C virus infection. Virol hepatitis Rev. 1, 59-65. |
13 | Krieger, M. 2001. Scavenger receptor class type I is a multiligand HDL receptor that influences diverse physiologic systems. J. Clin. Invest 108, 793-797. DOI ScienceOn |
14 | Agnello, V., G. Abel, M. Elfahal, G. B. Knight and Q. X. Zhang. 1999. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96, 12766-12771. DOI ScienceOn |
15 | Lindenbach, B. D and C. M. Rice. 2001. Hepatitis viruses and their replication, pp. 9911-1041. In Knipe, D. M and P. M. Howley (eds), Virology, Lippincott-Raven, Philadelphia. |
16 | Correas, I. 1991. Characterization of isoforms of protein 4.1 present in the nucleus. Biochem. J. 279, 581-585. |
17 | Ward, S. G., K. Bacon and J. Westwick. 1998. Chemokines and T lymphocytes: More than an attraction. Immunity 9, 1-11. DOI ScienceOn |
18 | Hadlock, K. G., R. E. Lanford, S. Perkins, J. Rowe, Q. Yang, S. Levy, P. Pileri, S. Abrignani and S. K. Foung. 2000. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J. Virol. 74, 10407-10416. DOI ScienceOn |
19 | Ikeda, M., N. Kato, T. Mizutani, K. Sugiyama, K. Tanaka and K. Shimotohno. 1997. Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes. J. of Hepatology 27, 445-454. DOI ScienceOn |
20 | Monazahian, M., I. Bohme, S. Bonk, A. Koch, C. Scholz, S. Grethe and R. Thomssen. 1999. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57, 223-229. DOI ScienceOn |
21 | Sheu, T. J., E. M. Schwarz, D. A. Martinez, R. J. O'Keefe, R. N. Rosier, M. J. Zuscik and J. E. Puzas. 2003. A phage display technique identifies a novel regulator of cell differentiation. J. Biol. Chem. 278, 438-443. DOI ScienceOn |
22 | Bardi, G., M. Lipp, M. Baggiolini and P. Loetscher. 2001. The T cell chemokine receptor CCR7 is internalized on stimulated with ELC, but not with SLC. Eur. J. Immunol. 31, 3291-3297. DOI ScienceOn |
23 | Takanami, I. 2003. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int. J. Cancer 105, 186-189. DOI ScienceOn |
24 | Gardner, J. P., R. J. Durso, R. R. Arrigale, G. P. Donovan, P. J. Maddon, T. Dragic and W. C. Olson. 2003. L-SIGN (CD209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 100, 4498-4503. DOI ScienceOn |
25 | De Beeck, A. O. and J. Dubuisson. 2003. Another putative receptor for hapatitis C virus. Hepatology 37, 705-707. DOI ScienceOn |
26 | Mashino, K., N. Sadanaga, H, Yamaguchi, F. Tanaka and M. Mori. 2002. Expression of chemokine receptor CCR7 is associated with lymph node metastasis if gastric carcinoma. Cancer Res. 92, 2937-2941. |
27 | Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verastegui and A. Zlotnik. 2001. Involvement of chemokine receptor in breast cancer metastasis. Nature 410, 50-56. DOI ScienceOn |
28 | Reed, K. E and C. M. Rice. 2000. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242, 55-84. |